167 related articles for article (PubMed ID: 31150809)
1. The obstacle course to the inner retina: Hyaluronic acid-coated lipoplexes cross the vitreous but fail to overcome the inner limiting membrane.
Devoldere J; Wels M; Peynshaert K; Dewitte H; De Smedt SC; Remaut K
Eur J Pharm Biopharm; 2019 Aug; 141():161-171. PubMed ID: 31150809
[TBL] [Abstract][Full Text] [Related]
2. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy.
Martens TF; Peynshaert K; Nascimento TL; Fattal E; Karlstetter M; Langmann T; Picaud S; Demeester J; De Smedt SC; Remaut K; Braeckmans K
Eur J Pharm Sci; 2017 May; 103():27-35. PubMed ID: 28223236
[TBL] [Abstract][Full Text] [Related]
3. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.
Martens TF; Remaut K; Deschout H; Engbersen JF; Hennink WE; van Steenbergen MJ; Demeester J; De Smedt SC; Braeckmans K
J Control Release; 2015 Mar; 202():83-92. PubMed ID: 25634806
[TBL] [Abstract][Full Text] [Related]
4. Non-viral delivery of chemically modified mRNA to the retina: Subretinal versus intravitreal administration.
Devoldere J; Peynshaert K; Dewitte H; Vanhove C; De Groef L; Moons L; Özcan SY; Dalkara D; De Smedt SC; Remaut K
J Control Release; 2019 Aug; 307():315-330. PubMed ID: 31265881
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid coating of gold nanoparticles for intraocular drug delivery: Evaluation of the surface properties and effect on their distribution.
Apaolaza PS; Busch M; Asin-Prieto E; Peynshaert K; Rathod R; Remaut K; Dünker N; Göpferich A
Exp Eye Res; 2020 Sep; 198():108151. PubMed ID: 32721426
[TBL] [Abstract][Full Text] [Related]
6. Vitreous: a barrier to nonviral ocular gene therapy.
Peeters L; Sanders NN; Braeckmans K; Boussery K; Van de Voorde J; De Smedt SC; Demeester J
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3553-61. PubMed ID: 16186333
[TBL] [Abstract][Full Text] [Related]
7. Origin and turnover of ECM proteins from the inner limiting membrane and vitreous body.
Halfter W; Dong S; Dong A; Eller AW; Nischt R
Eye (Lond); 2008 Oct; 22(10):1207-13. PubMed ID: 18344966
[TBL] [Abstract][Full Text] [Related]
8. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection.
Koo H; Moon H; Han H; Na JH; Huh MS; Park JH; Woo SJ; Park KH; Kwon IC; Kim K; Kim H
Biomaterials; 2012 Apr; 33(12):3485-93. PubMed ID: 22322197
[TBL] [Abstract][Full Text] [Related]
9. Challenges in non-viral ocular gene transfer.
Peeters L; Sanders NN; Demeester J; De Smedt SC
Biochem Soc Trans; 2007 Feb; 35(Pt 1):47-9. PubMed ID: 17233598
[TBL] [Abstract][Full Text] [Related]
10. Co-Injection of Sulfotyrosine Facilitates Retinal Uptake of Hyaluronic Acid Nanospheres Following Intravitreal Injection.
Eblimit A; Makia MS; Strayve D; Crane R; Conley SM; Sinha T; Acharya G; Al-Ubaidi MR; Naash MI
Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575586
[TBL] [Abstract][Full Text] [Related]
11. Improved Intravitreal AAV-Mediated Inner Retinal Gene Transduction after Surgical Internal Limiting Membrane Peeling in Cynomolgus Monkeys.
Takahashi K; Igarashi T; Miyake K; Kobayashi M; Yaguchi C; Iijima O; Yamazaki Y; Katakai Y; Miyake N; Kameya S; Shimada T; Takahashi H; Okada T
Mol Ther; 2017 Jan; 25(1):296-302. PubMed ID: 28129123
[TBL] [Abstract][Full Text] [Related]
12. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous.
Dalkara D; Kolstad KD; Caporale N; Visel M; Klimczak RR; Schaffer DV; Flannery JG
Mol Ther; 2009 Dec; 17(12):2096-102. PubMed ID: 19672248
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-modified cationic niosomes for ocular gene delivery: improving transfection efficiency in retinal pigment epithelium.
Qin Y; Tian Y; Liu Y; Li D; Zhang H; Yang Y; Qi J; Wang H; Gan L
J Pharm Pharmacol; 2018 Sep; 70(9):1139-1151. PubMed ID: 29931682
[TBL] [Abstract][Full Text] [Related]
14. Ocular barriers to retinal delivery of intravitreal liposomes: Impact of vitreoretinal interface.
Tavakoli S; Peynshaert K; Lajunen T; Devoldere J; Del Amo EM; Ruponen M; De Smedt SC; Remaut K; Urtti A
J Control Release; 2020 Dec; 328():952-961. PubMed ID: 33091527
[TBL] [Abstract][Full Text] [Related]
15. Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic Model.
Hutton-Smith LA; Gaffney EA; Byrne HM; Maini PK; Gadkar K; Mazer NA
Mol Pharm; 2017 Aug; 14(8):2690-2696. PubMed ID: 28631484
[TBL] [Abstract][Full Text] [Related]
16. A core-shell nanoplatform as a nonviral vector for targeted delivery of genes to the retina.
Tan G; Liu D; Zhu R; Pan H; Li J; Pan W
Acta Biomater; 2021 Oct; 134():605-620. PubMed ID: 34329781
[TBL] [Abstract][Full Text] [Related]
17. Theoretical Insights into the Retinal Dynamics of Vascular Endothelial Growth Factor in Patients Treated with Ranibizumab, Based on an Ocular Pharmacokinetic/Pharmacodynamic Model.
Hutton-Smith LA; Gaffney EA; Byrne HM; Caruso A; Maini PK; Mazer NA
Mol Pharm; 2018 Jul; 15(7):2770-2784. PubMed ID: 29734810
[TBL] [Abstract][Full Text] [Related]
18. Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease.
Vacca O; El Mathari B; Darche M; Sahel JA; Rendon A; Dalkara D
J Vis Exp; 2015 Apr; (98):. PubMed ID: 25938717
[TBL] [Abstract][Full Text] [Related]
19. Toward smart design of retinal drug carriers: a novel bovine retinal explant model to study the barrier role of the vitreoretinal interface.
Peynshaert K; Devoldere J; Forster V; Picaud S; Vanhove C; De Smedt SC; Remaut K
Drug Deliv; 2017 Nov; 24(1):1384-1394. PubMed ID: 28925755
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection.
Huang D; Chen YS; Thakur SS; Rupenthal ID
Eur J Pharm Biopharm; 2017 Oct; 119():125-136. PubMed ID: 28602870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
